NFKB1 and lung cancer: It also inhibited inflammatory factors and negatively regulated NF-κB signaling through the PPARγ pathway, suggesting DATS as a potential new chemopreventive treatment for lung cancer caused by tobacco use (Qu et al., 2024[157]).